| Oct 30 |
Takeda Pharmaceutical FQ2 Earnings Preview
|
| Oct 25 |
Takeda and BMC partner to decarbonise US healthcare sector
|
| Oct 24 |
Takeda and Boston Medical Center Announce Innovative Collaboration to Help Tackle Decarbonization Across Health Care Ecosystem
|
| Oct 23 |
Dengue is spreading and Sanofi is pulling the U.S. market’s only vaccine. What’s next?
|
| Oct 22 |
Deko and Shire Leasing partner to offer B2B leasing at checkout
|
| Oct 17 |
Alumis' Investigational Lead Candidate Supports Superior Profile Than Bristol Myers' Commercialized Drug, Analyst Sees 170% Stock Upside
|
| Oct 16 |
Takeda declines to exercise option for Wave's WVE-003
|
| Oct 15 |
Strategic Moves in the Japanese Market: T. Rowe Price Japan Fund's Focus on Takeda Pharmaceutical
|
| Oct 9 |
WAVE Life Sciences Ltd (WVE) Q2 2024 Earnings Call Highlights: Strategic Advances Amid Rising ...
|
| Oct 7 |
Takeda Pharmaceutical: An Interesting Option For Income Investors
|
